Pharmacovigilance (PV or PhV), also known as Drug Safety, as per WHO it is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. The word ‘Pharmacovigilance’ is derived from a Greek word ‘pharmakon’ which means ‘drug’ and vigilare, a Latin word which means ‘to keep watch’. Together with the WHO Collaborating Centre for International Drug Monitoring, Uppsala, WHO promotes PV at the country level. At the end of 2010, 134 countries were part of the WHO PV Programme. The objectives of PV Department are: to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.
Sensing the ethical need towards our consumers – KHPL started a Pharmacovigilance cell in 2009 and is expanding its horizons.
A team of trained specialists has baing appointed for PV cell .
We have a simple online form, where necessary fields are marked and can be easily filled up and submitted to our organization, for the people and doctors to report cases of adverse events.
Constant endeavours and programmes are established to upgrade and update the activities which syncs with the international standards.